Reimagining Drug Delivery
Novilla’s technology leverages a specific proprietary combination of a specialized class of ionic liquids called Deep Eutectic Solvents, which had not advanced to the clinical setting prior to the advent of large AI models. This technology delivers, through a non-invasive transdermal cream, an adequate amount of therapeutic locally while avoiding systemic effects.
-
Computational screening narrows down billions of formulation combinations to one or two that penetrate tissue far deeper than previously possible
-
Novilla’s novel ionic formulation creates a hostile environment that propels the drug product past the stratum corneum into deeper tissues in a manner that truly hasn’t been achievable before.
-
Novilla repurposes drugs that have demonstrated significant efficacy but have downstream side-effects when administered systemically. By minimizing the systemic exposure, the drug can be used effectively and safely.